![Stephanie Bewick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Stephanie Bewick served as the Chief Business Officer at Destiny Pharma Plc from 2021 to 2023.
Prior to that, she worked as the Vice President of Business Development at Summit Therapeutics, Inc. Dr. Bewick received an undergraduate degree from The University of Edinburgh and a doctorate from the University of Bristol.
Anciens postes connus de Stephanie Bewick
| Sociétés | Poste | Fin |
|---|---|---|
| DESY PHAR | Corporate Officer/Principal | 01/03/2023 |
| SUMMIT THERAPEUTICS INC. | Corporate Officer/Principal | - |
Formation de Stephanie Bewick
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Destiny Pharma Plc
 Destiny Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops novel antimicrobial products | Health Technology |
Summit Therapeutics, Inc.
 Summit Therapeutics, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
